Publications in collaboration with researchers from Universidade de Santiago de Compostela (16)

2024

  1. Bioequivalence risk assessment of oral formulations containing racemic ibuprofen through a chiral physiologically based pharmacokinetic model of ibuprofen enantiomers

    European Journal of Pharmaceutics and Biopharmaceutics, Vol. 199

  2. Conferencias

    ParaJournal: Revista de la Sociedad Española de Parasitología, Núm. 5, pp. 35-37

  3. Epidemiología y control de parasitosis IV: Comunicaciones Orales 4

    ParaJournal: Revista de la Sociedad Española de Parasitología, Núm. 5, pp. 107-114

  4. Sanidad animal, Salud humana y medio ambiente: perspectiva ''One Health'' I. Comunicaciones Orales 8

    ParaJournal: Revista de la Sociedad Española de Parasitología, Núm. 5, pp. 126-133

  5. Sanidad animal, Salud humana y medio ambiente: perspectiva ''One Health'' II. Comunicaciones Orales 9.

    ParaJournal: Revista de la Sociedad Española de Parasitología, Núm. 5, pp. 134-141

  6. Towards precision medicine of long-acting aripiprazole through population pharmacokinetic modelling

    Psychiatry Research, Vol. 333

2023

  1. Correction: A Review of Population Pharmacokinetic Analyses of Linezolid (Clinical Pharmacokinetics, (2022), 61, 6, (789-817), 10.1007/s40262-022-01125-2)

    Clinical Pharmacokinetics

2022

  1. A Review of Population Pharmacokinetic Analyses of Linezolid

    Clinical Pharmacokinetics, Vol. 61, Núm. 6, pp. 789-817

  2. Epidemiología y ecología II:: Comunicaciones orales 16

    ParaJournal: Revista de la Sociedad Española de Parasitología, Núm. 1, pp. 204-212

2021

  1. Review of pharmacokinetics and pharmacogenetics in atypical long-acting injectable antipsychotics

    Pharmaceutics, Vol. 13, Núm. 7

2019

  1. Pharmacokinetics of intravitreal anti-VEGF drugs in age-related macular degeneration

    Pharmaceutics, Vol. 11, Núm. 8

2017

  1. Fasciola spp: Mapping of the MF6 epitope and antigenic analysis of the MF6p/HDM family of heme-binding proteins

    PLoS ONE, Vol. 12, Núm. 11

2016

  1. Intestinal Permeability of β-Lapachone and Its Cyclodextrin Complexes and Physical Mixtures

    European Journal of Drug Metabolism and Pharmacokinetics, Vol. 41, Núm. 6, pp. 795-806

2015

  1. Higher physiopathogenicity by Fasciola gigantica than by the genetically close F. hepatica: Experimental long-term follow-up of biochemical markers

    Transactions of the Royal Society of Tropical Medicine and Hygiene, Vol. 110, Núm. 1, pp. 55-66

2009

  1. MM3-ELISA detection of Fasciola hepatica coproantigens in preserved human stool samples

    American Journal of Tropical Medicine and Hygiene, Vol. 81, Núm. 1, pp. 156-162

  2. MM3-ELISA evaluation of coproantigen release and serum antibody production in sheep experimentally infected with Fasciola hepatica and F. gigantica

    Veterinary Parasitology, Vol. 159, Núm. 1, pp. 77-81